Kintor Pharmaceutical (HKG:9939) said its long-time auditor PricewaterhouseCoopers will retire at the company's upcoming annual meeting in June, according to a Tuesday filing with the Hong Kong bourse.
The pharmaceutical company's shares fell nearly 7% in late morning trade Wednesday.
The firm said it planned to appoint Rongcheng (Hong Kong) as its new auditor.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments